Changes in expression of IL-1β influenced proteins in transplanted islet during development of diabetes in diabetes-prone BB rats

Diabetologia

Volumn 47, Issue 5, 2004, Pages 892-908

  Sparre, T ^a   Bjerre Christensen, U ^a   Gotfredsen, C F ^b   Mose Larsen, P ^c   Fey, S J ^c   Hjerno K ^c   Roepstorff, P ^c   Pociot, F ^a   Karlsen, A E ^a   Nerup, J ^a  

^a STENO DIABETES CENTER   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

BB rat; Cytokines; Diabetes; IL 1 ; Islet; Mass spectrometry; Pathogenesis; Proteome analysis; Transplantation; Two dimensional gel electrophoresis

Indexed keywords

INTERLEUKIN 1BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL TRANSPLANTATION; CONTROLLED STUDY; DISEASE COURSE; GEL ELECTROPHORESIS; IN SITU HYBRIDIZATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY CAPSULE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT;

ANIMALS; CELL SEPARATION; DIABETES MELLITUS, TYPE 1; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; INTERLEUKIN-1; ISLETS OF LANGERHANS; RATS; RATS, INBRED BB; RNA, MESSENGER;

EID: 2942596542     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1382-y     Document Type: Article

References (68)

1. Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619-633
2. Junker K, Egeberg J, Kromann H, Nerup J (1977) An autopsy study of the islets of Langerhans in acute onset juvenile diabetes mellitus. Acta Pathol Microbiol Scand Sect Pathol 85:699-706
3. Nerup J, Mandrup-Poulsen T, Helqvist S et al. (1994) On the pathogenesis of IDDM. Diabetologia 37 [Suppl 2]:S82-S89
4. Mandrup-Poulsen T (1996) The role of interleukin-1 in the pathogenesis of insulin-dependent diabetes mellitus. Diabetologia 39:1005-1029
5. Green IC, Delaney CA, Cunningham JM, Karmiris V, Southern C (1993) Interleukin-1 beta effects on cyclic GMP and cyclic AMP in cultured rat islets of Langerhans-arginine-dependence and relationship to insulin secretion. Diabetologia 36:9-16
6. Eizirik DL, Delaney CA, Green MH et al. (1996) Nitric oxide donors decrease the function and survival of human pancreatic islets. Mol Cell Endocrinol 118:71-83
7. Bonner-Weir S, Trent DF, Honey RN, Weir GC (1981) Responses of neonatal rat islets to streptozotocin: limited B-cell regeneration and hyperglycemia. Diabetes 30:64-69
8. Corbett JA, McDaniel ML (1995) Intraislet release of interleukin 1 inhibits beta-cell expression of inducible nitric oxide synthase. J Exp Med 181:559-568
9. Heitmeier MR, Arnush M, Scarim AL, Corbett JA (2001) Pancreatic beta-cell damage mediated by beta-cell production of interleukin-1 - a novel mechanism for virus-induced diabetes. J Biol Chem 276:11151-11158
10. Asayama K, Kooy NW, Burr IM (1986) Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets: decrease of islet manganosuperoxide dismutase. J Lab Clin Med 107:459-464
11. Sumoski W, Baquerizo H, Rabinovitch A (1989) Oxygen free radical scavengers protect rat islet cells from damage by cytokines. Diabetologia 32:792-796
12. Tiedge M, Lortz S, Munday R, Lenzen S (1998) Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species. Diabetes 47:1578-1585
13. Eizirik DL, Flodström M, Karlsen AE, Welsh N (1996) The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 39:875-890
14. Andersen HU, Fey SJ, Mose Larsen P et al. (1997) Interleukin-1beta induced changes in the protein expression of rat islets: a computerized database. Electrophoresis 18:2091-2103
15. John N, Andersen H, Fey S et al. (2000) Cytokine or chemically-derived nitric oxide alters the expression of proteins detected by two-dimensional gel electrophoresis in neonatal rat islets of Langerhans. Diabetes 49:1819-1829
16. Mose Larsen P, Fey SJ, Larsen MR et al. (2001) Proteome analysis of IL-1β induced changes in protein expression in rat islets of Langerhans. Diabetes 50:1056-1063
17. Benhamou PY, Moriscot C, Richard MJ et al. (1998) Adenovirus-mediated catalase gene-transfer reduces oxidant stress in human, porcine and rat pancreatic-islets. Diabetologia 41:1093-1100
18. Lortz S, Tiedge M, Nachtwey T, Karlsen AE, Nerup J, Lenzen S (2000) Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes. Diabetes 49:1123-1130
19. Bertera S, Crawford ML, Alexander AM et al. (2003) Gene transfer of manganese superoxide dismutase extends islet graft function in a mouse model of autoimmune diabetes. Diabetes 52:387-393
20. Lortz S, Tiedge M (2003) Sequential inactivation of reactive oxygen species by combined overexpression of SOD isoforms and catalase in insulin-producing cells. Free Radic Biol Med 34:683-688
21. Bone AJ (2000) Animal models of type I diabetes. Curr Opin Oncol Endocr Metab Invest Drugs 2:192-200
22. Nakhooda AF, Like AA, Chappel CI, Murray FT, Marliss EB (1977) The spontaneously diabetic Wistar rat. Metabolic and morphologic studies. Diabetes 26:100-112
23. Andersen HU, Mandrup-Poulsen T, Egeberg J, Helqvist S, Nerup J (1989) Genetically determined differences in new-born rat islet sensitivity to interleukin-1 in vitro: no association with the diabetes prone phenotype in the BB-rat. Acta Endocrinol (Copenh) 120:92-98
24. Reimers JI, Andersen HU, Mauricio D et al. (1996) Strain dependent differences in sensitivity of rat beta-cells to IL-1beta in vitro and in vivo: Association with islet nitric oxide synthesis. Diabetes 45:771-778
25. Bellmann K, Hui L, Radons J, Burkart V, Kolb H (1997) Low stress response enhances vulnerability of islet cells in diabetes-prone BB rats. Diabetes 46:232-236
26. Wachlin G, Heine L, Kloting I, Dunger A, Hahn HJ, Schmidt S (2002) Stress response to pancreatic islets from diabetes prone BB rats of different age. Autoimmunity 35:389-395
27. Christensen UB, Larsen PM, Fey SJ et al. (2000) Islet protein expression changes during diabetes development in islet syngrafts in BB-DP rats and during rejection of BB- DP islet allografts. Autoimmunity 32:1-15
28. Sparre T, Christensen UB, Larsen PM et al. (2002) IL-1β induced protein changes in diabetes prone BB rat islets of Langerhans identified by proteome analysis. Diabetologia 45:1550-1561
29. Christensen U, Sparre T, Cooke A, Andersen H, Mandrup-Poulsen T, Nerup J (1998) Syngeneic islet transplantation in prediabetic BB-DP rats-a synchronized model for studying beta-cell destruction during the development of IDDM. Autoimmunity 28:91-107
30. Brunstedt J, Nielsen JH, Lernmark Å, The Hagedorn Study Group (1984) Isolation of islets from mice and rats. In: Larner J, Pohl SL (eds) Methods in diabetes research. Laboratory methods, part C, vol 1. Wiley, New York, pp 254-288
31. Karlsen AE, Sparre T, Nielsen K, Nerup J, Pociot F (2001) Proteome analysis - a novel approach to understand the pathogenesis of Type 1 diabetes mellitus. Disease Mark 17:205-216
32. Weringer EJ, Like AA (1988) Identification of T cell subsets and class I and class II antigen expression in islet grafts and pancreatic islets of diabetic BioBreeding/ Worcester rats. Am J Pathol 132:292-303
33. Korsgren O, Jansson L, Sandler S, Andersson A (1990) Hyperglycemia- induced B cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background. J Clin Invest 86:2161-2168
34. O'Farrell PZ, Goodman HM, O'Farrell PH (1977) High resolution two dimentional electrophoresis of basic as well as acidic proteins. Cell 12:1133-1142
35. Fey SJ, Nawrocki A, Larsen MR et al. (1997) Proteome analysis of Saccharomyces cerevisiae: a methodological outline. Electrophoresis 18:1361-1372
36. Swiss-Prot. ExPASy Molecular Biology Server. Available from http://www.expasy.org, last accessed 17 October 2002, last updated 17 October 2002
37. The National Center for Biotechnology Information (NCBI). Available from http://www.ncbi.nlm.nih.gov, last accessed 17 October 2002, last updated 16 October 2002
38. Bokvist K, Olsen HL, Hoy M et al. (1999) Characterisation of sulphonylurea and ATP-regulated K+ channels in rat pancreatic A-cells. Pflugers Arch 438:428-436
39. Ankarcrona M, Dypbukt JM, Brune B, Nicotera P (1994) Interleukin-1 beta-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 213:172-177
40. Kaneto H, Fujii J, Seo HG et al. (1995) Apoptotic cell-death triggered by nitric-oxide in pancreatic beta-cells. Diabetes 44:733-738
41. L Vassiliadis S, Dragiotis V, Protopapadakis E et al. (1999) The destructive action of IL-1alpha and IL-1beta in IDDM is a multistage process: evidence and confirmation by apoptotic studies, induction of intermediates and electron microscopy. Mediators Inflamm 8:85-91
42. Maedler K, Sergeev P, Ris F et al. (2002) Glucose-induced beta cell production of IL-1 beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851-860
43. Freiesleben De Blasio B, Bak P, Pociot F, Karlsen AE, Nerup J (1999) Onset of type 1 diabetes: a dynamical instability. Diabetes 48:1677-1685
44. Mathis D, Vence L, Benoist C (2001) Beta-cell death during progression to diabetes. Nature 414:792-798
45. Rieneck K, Bovin LF, Josefsen K, Buschard K, Svenson M, Bendtzen K (2000) Massive parallel gene expression profiling of RINm5F pancreatic islet b-cells stimulated with interleukin-1b. APMIS 108:855-872
46. Cardozo AK, Kruhøffer M, Leeman R, Ørntoft T, Eizirik DL (2001) Identification of novel cytokine induced genes in pancreatic b-cells by high density oligonucleotide arrays. Diabetes 50:909-920
47. Kutlu B, Cardozo AK, Darville MI et al. (2003) Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes 52:2701-2719
48. Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielsen JH (1986) Affinity-purified human interleukin 1 is cytotoxic to isolated islets of Langerhans. Diabetologia 29:63-67
49. Helqvist S, Polla BS, Johannesen J, Nerup J (1991) Heat shock protein induction in rat pancreatic islets by recombinant human interleukin 1beta. Diabetologia 34:150-156
50. Andersen HU, Jørgensen KH, Egeberg J, Mandrup-Poulsen T, Nerup J (1994) Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans. Diabetes 43:770-777
51. Karlsen AE, Andersen HU, Vissing H et al. (1995) Cloning and expression of cytokine-inducible nitric oxide synthase cDNA from rat islets of Langerhans. Diabetes 44:753-758
52. Finegood DT, Scaglia L, Bonner-Weir S (1995) Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44:249-256
53. Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC (1996) Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 45:1161-1167
54. Bonner-Weir S (2001) Beta-Cell turnover: Its assessment and implications. Diabetes 50:S20-S24
55. Johannesen J, Pociot F, Karlsen AE, Mandrup-Poulsen T, Nerup J (2001) Strain-dependent difference in inducible nitric oxide synthesis (NOS) expression in rat pancreatic islets correlates with Interferon regulating factor 1 (IRF-1) and heat shock protein 70 (HSP70) expression. Eur Cytokine Network 12:501-509
56. Lotz MM, Andrews CW, Korzelius CA et al. (1993) Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci USA 90:3466-3470
57. Hsu DK, Dowling CA, Jeng KCG, Chen JT, Yang RY, Liu FT (1999) Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int J Cancer 81:519-526
58. Yang R (2003) Galectins in cell growth and apoptosis. Cell Mol Life Sci 60:267-276
59. Seimin O, Lucier GW, Clark GC et al. (1996) Isolation and characterization of a novel gene induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Carcinogenesis 17:2609-2615
60. Ishihara K, Hirano T (2002) IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 13:357-368
61. Sasaki T, Takai Y (1998) The Rho small G protein family-Rho GDI system as a temporal and spatial determinant for cytoskeletal control. Biochem Biophys Res Commun 245: 641-645
62. Toksoz D, Merdek KD (2002) The Rho small GTPase: functions in health and disease. Histol Histopath 17:915-927
63. Rabilloud T, Heller M, Gasnier F et al. (2002) Proteomics analysis of cellular response to oxidative stress - evidence for in vivo overoxidation of peroxiredoxins at their active site. J Biol Chem 277:19396-19401
64. McCormick DB, Chen H (1999) Update on interconversions of vitamin B-6 with its coenzyme. J Nutr 129:325-327
65. Hanna MC, Turner AJ, Kirkness EF (1997) Human pyridoxal kinase. cDNA cloning, expression, and modulation by ligands of the benzodiazepine receptor. J Biol Chem 272:10756-10760
66. Aaltonen J, Björses P, Sandkuijl L, Perheentupa J, Peltonen L (1994) An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nat Genet 8:83-87
67. Bjorses P, Aaltonen J, Vikman A et al. (1996) Genetic homogeneity of autoimmune polyglandular disease type I. Am J Hum Genet 59:879-886
68. Meyer G, Badenhoop K (2002) Autoimmune regulator (AIRE) gene on chromosome 21: Implications for auto-immune polyendocrinopathy-candidiasis - ectodermal dystrophy (APECED) and more common manifestations of endocrine autoimmunity. J Endocrinol Invest 25:804-811